Terms: = Thyroid cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
1282 results:
1. Multiple pathological fractures and muscle atrophy caused by a parathyroid carcinoma with postoperative hungry bone syndrome: A case report.
Liu Q; Zhang Y; Ma D; Gengzhi H; Maimaiti Y; Chen Q; Ma Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2047. PubMed ID: 38577726
[TBL] [Abstract] [Full Text] [Related]
2. Development and Preclinical Evaluation of [
El Fakiri M; Ayada N; Müller M; Hvass L; Gamzov TH; Clausen AS; Geis NM; Steinacker N; Hansson E; Lindegren S; Aneheim E; Jensen H; Eder AC; Jensen AI; Poulie CBM; Kjaer A; Eder M; Herth MM
J Nucl Med; 2024 Apr; 65(4):593-599. PubMed ID: 38423784
[TBL] [Abstract] [Full Text] [Related]
3. Discrepancies Between Morphological and Immunohistochemical Classifications Are Associated With Prognoses and Subtypes of Lung cancer.
Natsume K; Ye J; Mukai Y; Yamakawa K; Tanimoto M; Ito H; Miyagi Y; Daigo Y; Muto-Ishizuka M; Kadota K; Haba R; Suizu F
Anticancer Res; 2024 Feb; 44(2):711-722. PubMed ID: 38307593
[TBL] [Abstract] [Full Text] [Related]
4. Polyautoimmunity in Patients With Anticyclic Citrullinated Peptide Antibody-Positive and -Negative Rheumatoid Arthritis: a Nationwide Cohort Study From Denmark.
Kristensen S; Hagelskjær AM; Cordtz R; Bliddal S; Mortensen AS; Nielsen CH; Feldt-Rasmussen U; Lauridsen KB; Dreyer L
J Rheumatol; 2024 Apr; 51(4):350-359. PubMed ID: 38302173
[TBL] [Abstract] [Full Text] [Related]
5. Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications.
Sterenborg RBTM; Steinbrenner I; Li Y; Bujnis MN; Naito T; Marouli E; Galesloot TE; Babajide O; Andreasen L; Astrup A; Åsvold BO; Bandinelli S; Beekman M; Beilby JP; Bork-Jensen J; Boutin T; Brody JA; Brown SJ; Brumpton B; Campbell PJ; Cappola AR; Ceresini G; Chaker L; Chasman DI; Concas MP; Coutinho de Almeida R; Cross SM; Cucca F; Deary IJ; Kjaergaard AD; Echouffo Tcheugui JB; Ellervik C; Eriksson JG; Ferrucci L; Freudenberg J; ; ; Fuchsberger C; Gieger C; Giulianini F; Gögele M; Graham SE; Grarup N; Gunjača I; Hansen T; Harding BN; Harris SE; Haunsø S; Hayward C; Hui J; Ittermann T; Jukema JW; Kajantie E; Kanters JK; Kårhus LL; Kiemeney LALM; Kloppenburg M; Kühnel B; Lahti J; Langenberg C; Lapauw B; Leese G; Li S; Liewald DCM; Linneberg A; Lominchar JVT; Luan J; Martin NG; Matana A; Meima ME; Meitinger T; Meulenbelt I; Mitchell BD; Møllehave LT; Mora S; Naitza S; Nauck M; Netea-Maier RT; Noordam R; Nursyifa C; Okada Y; Onano S; Papadopoulou A; Palmer CNA; Pattaro C; Pedersen O; Peters A; Pietzner M; Polašek O; Pramstaller PP; Psaty BM; Punda A; Ray D; Redmond P; Richards JB; Ridker PM; Russ TC; Ryan KA; Olesen MS; Schultheiss UT; Selvin E; Siddiqui MK; Sidore C; Slagboom PE; Sørensen TIA; Soto-Pedre E; Spector TD; Spedicati B; Srinivasan S; Starr JM; Stott DJ; Tanaka T; Torlak V; Trompet S; Tuhkanen J; Uitterlinden AG; van den Akker EB; van den Eynde T; van der Klauw MM; van Heemst D; Verroken C; Visser WE; Vojinovic D; Völzke H; Waldenberger M; Walsh JP; Wareham NJ; Weiss S; Willer CJ; Wilson SG; Wolffenbuttel BHR; Wouters HJCM; Wright MJ; Yang Q; Zemunik T; Zhou W; Zhu G; Zöllner S; Smit JWA; Peeters RP; Köttgen A; Teumer A; Medici M
Nat Commun; 2024 Jan; 15(1):888. PubMed ID: 38291025
[TBL] [Abstract] [Full Text] [Related]
6. Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer.
Cho BC; Chiu CH; Massarelli E; Buchschacher GL; Goto K; Overbeck TR; Loong HHF; Chee CE; Garrido P; Dong X; Fan Y; Lu S; Schwemmers S; Bordogna W; Zeuner H; Osborne S; John T
Lung Cancer; 2024 Feb; 188():107442. PubMed ID: 38171156
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic Performance of [
Ventura D; Dittmann M; Büther F; Schäfers M; Rahbar K; Hescheler D; Claesener M; Schindler P; Riemann B; Seifert R; Roll W
J Nucl Med; 2024 Feb; 65(2):192-198. PubMed ID: 38164565
[TBL] [Abstract] [Full Text] [Related]
8. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated thyroid cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
9. Air quality and cancer risk in the All of Us Research Program.
Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
[TBL] [Abstract] [Full Text] [Related]
10. Social Vulnerability Association with thyroid cancer Disparities in the United States.
Fei-Zhang DJ; Verma R; Arimoto R; Lawrence AS; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
Thyroid; 2024 Feb; 34(2):225-233. PubMed ID: 38069566
[No Abstract] [Full Text] [Related]
11. Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated thyroid cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.
Capdevila J; Krajewska J; Hernando J; Robinson B; Sherman SI; Jarzab B; Lin CC; Vaisman F; Hoff AO; Hitre E; Bowles DW; Williamson D; Levytskyy R; Oliver J; Keam B; Brose MS
Thyroid; 2024 Mar; 34(3):347-359. PubMed ID: 38062732
[No Abstract] [Full Text] [Related]
12. US Risk Stratification System for Follicular thyroid Neoplasms.
Li J; Li C; Zhou X; Huang J; Yang P; Cang Y; Zhai H; Huang R; Mu Y; Gou X; Zhang Y; Yu J; Liang P
Radiology; 2023 Nov; 309(2):e230949. PubMed ID: 37987664
[TBL] [Abstract] [Full Text] [Related]
13. A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
Ho AL; Foster NR; Deraje Vasudeva S; Katabi N; Antonescu CR; Frenette GP; Pfister DG; Erlichman C; Schwartz GK
Cancer; 2024 Mar; 130(5):702-712. PubMed ID: 37947157
[TBL] [Abstract] [Full Text] [Related]
14. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [
Günther T; Holzleitner N; Viering O; Beck R; Wienand G; Dierks A; Pfob CH; Bundschuh RA; Kircher M; Lapa C; Wester HJ
J Nucl Med; 2024 Jan; 65(1):33-39. PubMed ID: 37945383
[TBL] [Abstract] [Full Text] [Related]
15. thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
Gimblet GR; Whitt J; Houson HA; Lin D; Guenter R; Rao TC; Wang D; Ness J; Gonzalez ML; Murphy MS; Gillis A; Chen H; Copland JA; Kenderian SS; Lloyd RV; Szkudlinski MW; Lapi SE; Jaskula-Sztul R
Surgery; 2024 Jan; 175(1):199-206. PubMed ID: 37919223
[TBL] [Abstract] [Full Text] [Related]
16. Risk stratification of papillary thyroid cancers using multidimensional machine learning.
Li Y; Wu F; Ge W; Zhang Y; Hu Y; Zhao L; Gou W; Shi J; Ni Y; Li L; Fu W; Lin X; Yu Y; Han Z; Chen C; Xu R; Zhang S; Zhou L; Pan G; Peng Y; Mao L; Zhou T; Zheng J; Zheng H; Sun Y; Guo T; Luo D
Int J Surg; 2024 Jan; 110(1):372-384. PubMed ID: 37916932
[TBL] [Abstract] [Full Text] [Related]
17. US Predictors of Papillary thyroid Microcarcinoma Progression at Active Surveillance.
Lee JY; Kim JH; Kim YK; Lee CY; Lee EK; Moon JH; Choi HS; Yul H; Cho SW; Kim SJ; Lee KE; Park DJ; Park YJ
Radiology; 2023 Oct; 309(1):e230006. PubMed ID: 37906009
[TBL] [Abstract] [Full Text] [Related]
18. Phase 3 Trial of Selpercatinib in Advanced
Hadoux J; Elisei R; Brose MS; Hoff AO; Robinson BG; Gao M; Jarzab B; Isaev P; Kopeckova K; Wadsley J; Führer D; Keam B; Bardet S; Sherman EJ; Tahara M; Hu MI; Singh R; Lin Y; Soldatenkova V; Wright J; Lin B; Maeda P; Capdevila J; Wirth LJ;
N Engl J Med; 2023 Nov; 389(20):1851-1861. PubMed ID: 37870969
[TBL] [Abstract] [Full Text] [Related]
19. Early Increases in Blood Pressure and Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma and thyroid cancer Treated With VEGFR TKIs.
Narayan V; Liu T; Song Y; Mitchell J; Sicks J; Gareen I; Sun L; Denduluri S; Fisher C; Manikowski J; Wojtowicz M; Vadakara J; Haas N; Margulies KB; Ky B
J Natl Compr Canc Netw; 2023 Oct; 21(10):1039-1049.e10. PubMed ID: 37856199
[TBL] [Abstract] [Full Text] [Related]
20. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
Diao Z; Zhang J; Zhao J; Sun W; Pu Z
BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
[TBL] [Abstract] [Full Text] [Related]
[Next]
